Chemist Warehouse MILITARY

Target: Chemist Warehouse / CW Group Holdings Limited Parent: Sigma Healthcare Limited Research date: 23 October 2026 Evidence period: Historical corporate records through October 2026 Domain: Defence, security, military supply chains, and military-linked settlement activity

Direct Defence Contracting & Procurement

Corporate identity and operating structure

Chemist Warehouse developed from the pharmacy businesses established by Jack and Sam Gance, with Mario Verrocchi subsequently joining the business; the first Chemist Warehouse store opened in 2000, and the business expanded primarily through pharmacy retailing and franchising.¹

On 12 February 2025, Sigma Healthcare acquired 100% of the issued shares in CW Group Holdings Limited, making Chemist Warehouse a wholly owned subsidiary; Sigma publicly announced completion of the merger on 13 February 2025.^{2, 3}

The merged business combines pharmacy retailing, franchise support, pharmaceutical wholesaling, and distribution infrastructure.⁴

The February 2025 transaction also brought Jack Gance, Mario Verrocchi, Damien Gance, and Danielle Di Pilla onto the Sigma board, providing an identifiable group of principals for military-industry screening.⁵

Israeli Ministry of Defence and IDF contracts

No public evidence identified of a contract, tender award, framework agreement, or memorandum between Chemist Warehouse, Sigma Healthcare, or their identified pharmacy businesses and the Israeli Ministry of Defence, IDF, Israel Prison Service, or Israel Border Police in the reviewed corporate and military-pharmacy material.^{3, 4, 6}

Defence trade directories

No public evidence identified of Chemist Warehouse or Sigma Healthcare offering defence equipment, military products, or specialist military procurement services in the reviewed operating disclosures.^{1, 4}

Defence partnerships and announcements

No public evidence identified of an Israeli defence cooperation agreement, defence joint venture, or military procurement partnership in the reviewed corporate announcements and business descriptions.^{2, 3}

Controlling principals

Contemporary corporate and merger reporting identifies Jack Gance, Sam Gance, Mario Verrocchi, Damien Gance, Danielle Di Pilla, and Vikesh Ramsunder as relevant founders, shareholders, directors, or senior executives of the combined business.^{1, 5, 7}

No public evidence identified in the reviewed sources of Israeli defence-company directorships, Israeli military procurement positions, military-specific donations, or defence-manufacturing ownership interests attributable to these named individuals or their identified business vehicles.^{5, 7}

Dual-Use Products & Tactical Variants

Civilian product range

Sigma describes its operations as pharmaceutical wholesaling, pharmacy franchising, healthcare retail support, and distribution to community pharmacies.⁴

The corporate description identifies healthcare and medicine distribution as ordinary commercial activities; it does not document a Chemist Warehouse military-specific pharmaceutical product line or tactical equipment business.⁴

Militarised products

No public evidence identified of Chemist Warehouse manufacturing or marketing tactical medical equipment, military field-care systems, combat medical packs, or defence-specified pharmaceutical products for Israeli security organisations.^{1, 4}

Civilian and military end users

The IDF publishes procedures for soldiers obtaining medication through military pharmacies and specified participating civilian pharmacies, demonstrating that Israeli military prescription arrangements can include civilian pharmacy providers.⁶

The reviewed IDF information does not establish Chemist Warehouse as a participating pharmacy, military supplier, or contractual beneficiary of those arrangements.⁶

End-user certification and licensing

No public evidence identified of Chemist Warehouse-specific military end-user certificates, dual-use export licences, or Israeli defence-end-user authorisations in the reviewed operating and procurement material.^{4, 6}

Heavy Machinery, Construction & Infrastructure

Relevant corporate activities

Sigma’s corporate description concerns healthcare retailing, wholesaling, franchise support, and pharmaceutical distribution, rather than construction machinery manufacturing or civil engineering contracting.⁴

Equipment in occupied territories

No public evidence identified of Chemist Warehouse-owned or Chemist Warehouse-supplied machinery being used for settlement construction, checkpoint infrastructure, military installations, demolition, or land clearance in the occupied Palestinian territory.^{4, 8}

Direct and indirect supply

Human Rights Watch’s [pre-2020] investigation documents settlement-business mechanisms involving construction, infrastructure services, and commercially supplied equipment, but provides no established Chemist Warehouse-specific supply relationship in the reviewed material; no continuing Chemist Warehouse relationship is confirmed.⁸

Construction and engineering contracts

No public evidence identified of Chemist Warehouse or Sigma Healthcare contracting for construction or maintenance of Israeli military bases, detention facilities, settlement infrastructure, checkpoints, or separation-barrier installations.^{4, 9}

Settlement locations

Sigma identifies international pharmacy activities in New Zealand, Ireland, China, and Dubai alongside its Australian operations; its reviewed geographic description does not establish a Chemist Warehouse operation in the West Bank, East Jerusalem, or Golan Heights.⁴

Supply Chain Integration with Defence Primes

Pharmaceutical supply chain

Sigma describes the combined business as a pharmaceutical wholesaler and retail pharmacy franchisor serving community healthcare markets.⁴

Its corporate history identifies a broad pharmacy network and pharmaceutical distribution operations following the 2025 combination.¹

Israeli defence manufacturers

No public evidence identified of Chemist Warehouse supplying components, manufacturing inputs, pharmaceuticals under military-specific contracts, or specialist services to Elbit Systems, Israel Aerospace Industries, Rafael Advanced Defense Systems, or Israel Military Industries.^{4, 10}

Component categories

No public evidence identified of Chemist Warehouse supplying guidance equipment, electronic assemblies, military optics, structural materials, propulsion systems, or other components designed for Israeli defence platforms.^{4, 10}

Joint development and co-production

No public evidence identified of an Israeli military research partnership, technology-transfer agreement, licensed weapons manufacturing programme, or defence co-production arrangement involving Chemist Warehouse.^{1, 4}

Group attribution

The February 2025 acquisition created a formal parent-subsidiary relationship between Sigma Healthcare and Chemist Warehouse, making the merged group’s documented pharmaceutical wholesale and distribution operations relevant to the search.^{3, 11}

The reviewed combined-group disclosures did not identify Israeli defence-prime integration through those operations.^{2, 4}

Logistical Sustainment & Base Services

Distribution infrastructure

The combined Sigma and Chemist Warehouse business uses pharmaceutical wholesaling and distribution infrastructure to support pharmacies and healthcare suppliers.^{2, 4}

Military installation services

No public evidence identified of Chemist Warehouse or Sigma Healthcare providing contracted medical logistics, catering, transport, facilities maintenance, fuel, telecommunications, or other base-support services to Israeli military installations.^{4, 6}

Military pharmaceutical supply

The IDF identifies military pharmacies and arrangements under which qualifying prescriptions may be fulfilled through specified civilian pharmacies.⁶

No Chemist Warehouse-specific prescription arrangement, military pharmacy supply agreement, or procurement award was established from that official material.⁶

Occupied-territory installations

No public evidence identified of Chemist Warehouse providing logistics or medical-supply services to Israeli security installations in the West Bank, East Jerusalem, Golan Heights, or other occupied territories.^{4, 6}

Shipping, freight, and ports

No public evidence identified of Chemist Warehouse or Sigma Healthcare transporting Israeli military cargo, providing military freight forwarding, or operating defence-specific port-handling services.^{4, 12}

Civilian distribution distinction

The company’s disclosed wholesale and retail distribution activities establish civilian pharmaceutical logistics operations, without identifying a contractual Israeli military end user.^{4, 12}

Munitions, Weapons Systems & Strategic Platforms

Lethal weapons manufacturing

No public evidence identified of Chemist Warehouse or Sigma Healthcare designing, producing, integrating, or maintaining firearms, artillery, armoured vehicles, weaponised drones, military aircraft, naval weapons, or lethal military platforms.^{1, 4}

Munitions and precursor materials

No public evidence identified of Chemist Warehouse manufacturing or supplying ammunition, explosives, chemical propellants, warhead components, or military munitions precursors to Israel.^{4, 13}

Strategic defence platforms

No public evidence identified of Chemist Warehouse participation in Iron Dome, David’s Sling, Arrow, military aircraft, warship, main battle tank, or ballistic missile procurement or production.^{4, 13}

Critical military subsystems

No public evidence identified of Chemist Warehouse supplying fire-control systems, targeting software, guidance electronics, military radar systems, or purpose-built kinetic targeting AI.^{4, 10}

Civilian technology distinction

The documented business includes civilian digital health and retail-related activity, but the reviewed corporate description does not identify purpose-built weapons guidance, fire-control automation, or military targeting products.¹

Export Licensing, Regulatory & Legal History

Corporate regulatory background

Sigma is an Australian listed company, and the February 2025 transaction involved acquisition of Chemist Warehouse’s issued shares through a scheme of arrangement.^{3, 14}

The transaction followed shareholder approval and resulted in former Chemist Warehouse shareholders receiving a controlling ownership position in the combined business.^{7, 3}

Military export licences

No public evidence identified of a licence granted, denied, suspended, or revoked for Chemist Warehouse exports to Israeli military or security end users in the reviewed corporate and procurement material.^{3, 4}

Arms embargoes and sanctions

No public evidence identified of a Chemist Warehouse-specific arms embargo enforcement proceeding, Israeli defence-export sanctions action, or military end-use compliance investigation.^{4, 14}

Legal challenges

No public evidence identified of litigation or judicial review concerning Chemist Warehouse’s alleged supply of weapons, military equipment, or services to Israeli defence organisations.^{3, 14}

Constructive notice and continuation

The Chemist Warehouse–Sigma merger occurred in February 2025, after the 19 July 2024 ICJ advisory opinion and the November 2024 ICC arrest warrants discussed in contemporary BDS corporate accountability material.^{3, 15}

No verified Israeli military supply relationship was established in the reviewed material for which continued performance after those dates could be documented.^{4, 15}

Civil Society Scrutiny & Documented Investigations

AFSC Investigate

AFSC Investigate maintains a company database focused on businesses with demonstrated connections to Israeli military occupation and specified serious human-rights violations.¹⁶

Its methodology explains that the database is selective and does not encompass every Israeli company or every company conducting business with Israel.¹⁷

The reviewed AFSC company material did not establish a named Chemist Warehouse military, security, or settlement-related case.¹⁸

Human Rights Watch

Human Rights Watch’s [pre-2020] settlement-business investigation documents how private companies can facilitate settlement construction, financing, maintenance, and commercial activity; the historical investigation does not establish a Chemist Warehouse-specific relationship in the material reviewed, and no ongoing relationship is confirmed.⁸

A separate [pre-2020] Human Rights Watch statement addresses companies operating in or providing services to settlements; no Chemist Warehouse-specific military supply or settlement service is established by that statement, and no ongoing relationship is confirmed.⁹

Human Rights Watch’s [pre-2020] recommendations concerning the UN settlement-business database explain relevant categories of business activity, including settlement services and financial operations; no Chemist Warehouse-specific involvement is established by those recommendations, and no ongoing relationship is confirmed.¹⁹

Amnesty International

Amnesty International’s February 2020 reporting discusses the initial UN database of businesses associated with Israeli settlements, including named tourism businesses; the reviewed article does not establish Chemist Warehouse military or settlement involvement.²⁰

Boycott and divestment activity

The BDS Movement publishes guidance distinguishing priority boycott targets, divestment targets, and other corporate pressure campaigns.²¹

Its current campaign listings identify organised initiatives directed at named companies and sectors, but no Chemist Warehouse-specific Israeli military-supply campaign was established in the reviewed listings.²²

The BDS Movement’s technology campaign identifies companies targeted over alleged military and security technology relationships, without establishing Chemist Warehouse as a participant in those relationships.²³

The movement’s February 2026 campaign communication identifies particular consumer brands and alleged Israeli military-support relationships; it does not establish a Chemist Warehouse military donation or supply arrangement.²⁴

Corporate response

No public evidence identified of a Chemist Warehouse statement acknowledging an Israeli defence contract, terminating a military supply arrangement, or introducing military-specific end-use monitoring in response to an identified boycott campaign.^{2, 21}

Institutional divestment

No public evidence identified in the reviewed AFSC and BDS material of an institutional divestment decision expressly concerning Chemist Warehouse’s alleged Israeli military supply activities.^{16, 25}

Evidence boundaries

AFSC’s published selection criteria and the BDS Movement’s campaign guidance establish that the existence of wider Israeli military supply networks or campaigns concerning other companies does not itself document a Chemist Warehouse contractual relationship.^{17, 21}